An interesting study reporting the successful local delivery of LNPs to the lungs following nasal administration was carried out by Robinson et al. who developed LNP delivering CF transmembrane conductance regulator mRNA for the treatment of CF [108]. The gene discussed is CFTR; the disease is cystic fibrosis.